中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2011, Vol. 46 Issue (15) :1137-1141    DOI:
���� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << [an error occurred while processing this directive] | [an error occurred while processing this directive] >>
2010���ҹ�����ҩ���о���չ
����ɽ��̷������������
ɽ����ѧҩѧԺ���������\��ҩ���о����������ǹ��̼����о����ģ����� 250012

Download: PDF (921KB)   HTML (0KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� ����2010���ҹ�����ҩ����о���չ������ ���Ĺ������ף�ѡ����нϴ�ѧ�������ʵ�ü�ֵ�����ݣ�����Ϲ��ʲ�������о����������ᡢ�ĺ͵������ࡢø�͸�ø�ࡢ���ࡢ֬���༰������ҩ��ֱ���ܲ��������״���бȶԡ���������� �����ᡢ�ĺ͵������ࡢø�͸�ø�ࡢ����ҩ��Ĺ������о����϶࣬��Ҫ��������Щҩ���ҩ�����ü����ơ����������ٴ�Ӧ�õȷ��档
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
�ؼ����� ����ҩ��   �о���չ   ������   �ĺ͵�����   ø   ֬��   ����     
Abstract��
Keywords��   
�ո�����: 2011-11-11;
���ñ���:   
.2010���ҹ�����ҩ���о���չ[J]  �й�ҩѧ��־, 2011,V46(15): 1137-1141
.[J]  Chinese Pharmaceutical Journal, 2011,V46(15): 1137-1141
��
[1] ZHANG T M, WANG F S. Progress on biochemical drugs in China during 1989[J]. Chin Pharm J(�й�ҩѧ��־), 1990, 25(12)�� 707-709. [2] ZHANG T M, TAN H N, WANG F S. Progress on biochemical drugs in China during 2005[J]. Chin Pharm J(�й�ҩѧ��־), 2006, 41(9)��641-645. . [3] ZHANG T M, ZONG A Z, WANG F S. Progress on biochemical drugs in China during 2007[J]. Chin Pharm J(�й�ҩѧ��־), 2008, 43(18)�� 1364-368. [4] ZHANG T M, ZONG A Z, WANG F S. Progress on biochemical drugs in China during 2008[J]. Chin Pharm J(�й�ҩѧ��־), 2009, 44(20)�� 1521-1525. [5] ZHANG T M, TAN H N, WANG F S. Progress on biochemical drugs in China during 2009[J]. Chin Pharm J(�й�ҩѧ��־), 2010, 45(21)��1601-1606. [6] ZENG X L, OU S L, ZHANG S Y, et al. Protective efects of N-acetylcysteine against lung ischemia-reperfusion injury in rats[J]. J Clin Pulm Med Chin(�ٴ��ο���־), 2010, 15(5)�� 621-623. [7] FAN H Y, REN K, GU R S, et al. Inhibition effect of taurine on myocarditis and myocardial fibrosis followed by myocarditis[J]. Chin Pharm J(�й�ҩѧ��־), 2010, 45(13)�� 997-1001. [8] WANG L F��YIN Y Q��ZHAO L, et al. Effects of taurine-magnesium coordination compound on sodium channel in rat cardiomyocytes of arrhythmia induced by aconitine[J]. Chin Pharmacol Bull(�й�ҩ��ѧͨ��), 2010, 26(5)��611-614. [9] XIE H, YANG B, ZHOU X M, et al. L-carnitine and taurine synergistically inhibit the proliferation and osteoblastic differentiatiion of vascular smooth muscle cells[J]. Acta Pharmacol Sin(�й�ҩ��ѧ��), 2010, 31(3)��289-296. [10] ZUO L Y��YU H Y��SUN W W, et al. Effect of thymosin-alphal on Thl and Th2 cytokine synthesis in patients with early phase of hepatic failure[J]. Chin J Biochem Pharm(�й�����ҩ����־), 2010, 31(2)�� 135-136. [11] LIU Q F, ZHANG H, ZHOU G C, et al. In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants[J]. Int J Pharm, 2010, 397 (1-2)�� 122-129. [12] LIU S, LI Y, WANG L Q, et al. Determination of reduced glutathione tablets with near infrared diffuse reflectance spectroscopy and PLS [J]. Chin J Pharm(�й�ҽҩ��ҵ��־), 2010, 41(11)�� 845-848. [13] XU L, ZHANG W D , WANG Z P, et al. Effect of polypeptide extract from scorpion venom ( PESV) on immune escape of lewis lung carcinomas[J]. China J Chin Mater Med(�й���ҩ��־), 2010, 35(17)�� 2324-2327. [14] LIU Q T, YU R, CUI Y X, et al. Preparation of pig spleen peptides by enzymatic hydrolysis and its biological activity[J]. Food Drug(ʳƷ��ҩƷ), 2010, 12(5)�� 161-164. [15] DAI L. The efficacy of salmon calcitonin combined with caltrate D in treatment of diabetes mellitus complicated with osteoporosis[J]. Chin Pratl Med(�й�ʵ��ҽҩ), 2010, 5(29)�� 36-38. [16] ZHU W, WANG Y Q. Antioxidant activity of collagen extracted from jellyfis[J]. Chin J Bioproc Eng (����ӹ�����), 2010, 8(2)�� 65-68. [17] LIU J, TANG L L, LIAO X X, et al. Efects of hirudin on ventricular arrhythmia after acute myocardial infarction in rats[J]. J Sun-Yatsen Univ(Med Sci)[��ɽ��ѧѧ����ҽѧ��ѧ�棩], 2010, 31(1)�� 50-54. [18] CUI Y T, ZHANG P, LIU Y M, et al. Study of administration route of insulin for the diabetic patients after esophagectomy during the time of enteral nutrition[J]. J Tianjin Med Univ (���ҽ�ƴ�ѧѧ��), 2010, 162��121����201-203��218. [19] HAO S L, YANG H X, FAN H H. Defibrase national standard for collaborative calibration [J]. Chin J Pharm Anal(ҩ�������־)�� 2010, 30(6)��1022-1025. [20] WANG B Q, PANG X B, LI Z H, et al. The process improvement on the separation and purification of superoxide dismutase from pig blood and its oxidation resistance[J]. Biotech Bull(���\��ͨ��), 2010, 2�� 168-172. [21] LIU J F, ZHAO T, TAN H N, et al. Pharmacokinetic analysis of in vivo disposition of heparin-superoxide dismutase[J]. Biomed Pharmacother, 2010, 64 (10)�� 686-691. [22] SHAO Y Y, NIE F H, MA J J. Efiects of the nattokinase for coagulation in vivo and in vitro in rats[J]. J Med Sci Yanbian Univ(�ӱߴ�ѧҽѧѧ��), 2010, 33(1)�� 10-12. [23] LIU Y Y, YANG Q S, GAO F. Acutobin combined with ozagrel sodium for acute cerebral infarction[J]. Chin Pharm (�й�ҩ��), 2010, 21(47)�� 4504-4505. [24] LI B S, LUO C Y, HE Y Y, et al. Relationship between the antileukemic activity of L-asparaginase and Asn level around leukemic cells[J]. Chin J Contemp Pediatr(�й�����������־), 2010, 12(7)�� 557-562. [25] FAN K, MA X F, XIE M, et al. Determination of PEG-uricase concentration in plasma by RP-HPLC[J]. J Chongqing Univ Tech (Nat Sci)[��������ѧѧ��(��Ȼ��ѧ)], 2010, 24(5)�� 29-32. [26] CHEN H, YU C M, QIN Y, et al. Set up the method of related substances in coenzyme Q10 and sodium chloride injection and study on its stability[J]. Chin J Clin Rat Drag Use (�ٴ�������ҩ), 2010, 3(12)�� 42-43. [27] LI Y C, ZHU S, GAO X D, et al. Determination of glucosamine hydrochloride by RP-HPLC[J]. J Nanchang Univ (Med Sci) [�ϲ���ѧѧ��(ҽѧ��)], 2010, 50(5)�� 96-97. [28] LI J J, LU Y H, TAN L, et al. Separation and determination of impurities in heparin sodium simultaneously by capillary electrophoresis[J]. Chin Pharm J(�й�ҩѧ��־), 2010, 45(15)�� 1179-1182. [29] ZHAO X, LI G S, YU G L, et al. Analysis of oversulfated chondroitin sulfate in contaminated heparin by precolumn derivatization high performance liquid chromatography[J]. Chem J Chin Univ(�ߵ�ѧУ��ѧѧ��), 2010, 45(15)�� 479-483. [30] KEIRE D A, MANS D J, YE H, et al. Assay of possible economically motivated additives or native impurities levels in heparin by 1H-NMR, SAX-HPLC, and anticoagulation time approaches[J]. J Pharm Biomed Anal, 2001, 52(5)�� 656-664. [31] LI D, HOU H M. Oral cavity delivery system of unfractionated and low molecular weight heparin[J]. Acta Pharm Sin(ҩѧѧ��), 2010, 45 (10)��1317-1321. [32] CHEN K, HU X. The study of treatment eficacy of the nephritic syndrome with low molecular weight heparin in children[J]. Chin J Biochem Pharm(�й�����ҩ����־), 2010, 31(3)�� 208-209. [33] LU S R, MAO Y, YU H, et al. Effect of low molecular weight heparin on growth, metastasis, and CXCR4 expression of orthotopicly transplanted gastric tumor in nude mice[J]. Tumor(����), 2010, 30(7)�� 591-595. [34] LI B, ZHENG X C, CHEN L B, et al. Preparation and characterization of porous chitosan microspheres[J]. J Nanjing Univ (Nat Sci) [�Ͼ���ѧѧ��(��Ȼ��ѧ)], 2010, 46(2)�� 186-191. [35] LIU X Y, SUN C X, LI J, et al. Preparation of zwitterionic polysaccharides and their effects on lymphocyte proliferation in vitro and in vivo[J]. J Northeast Normal Univ(Nat Sci Ed) [����ʦ��ѧ��(��Ȼ��ѧ��)], 2010, 42(2)�� 110-114. [36] PLAPIED L, VANDERMEULEN G, VROMAN B, et al. Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery[J]. Int J Pharm, 2010, 398(1-2)�� 210-218. [37] YE Q W��LU L Y��LI X S. Study on screening and mutation of high hyaluronic acid-producing strain[J]. Chem Bioeng(��ѧ�����﹤��), 2010, 27(3)�� 51-54. [38] WU H C��MA Q Y��DENG J, et al. Study on the pretreatment of broth of hyaluronic acid[J]. Biotechnology (���\��), 2010, 20(1)�� 81-84. [39] WU M X, DENG J, WU H C. Effect of temperature on production of hyaluronic acid[J]. Amino Acids Biotic Resour(��������������Դ), 2010, 30(1)�� 33-36. [40] LI S B, WEI X Y, LIU D, et al. Preparation and in vitro transdermal delivery of prostaglandin E1 microemulsion[J]. Chin J New Drugs(�й���ҩ��־), 2010, 19 (21)�� 2001-2004. [41] FANG W T, LI H J, ZHOU L S. Protective effects of prostaglandin E1 on human umbilical vein endothelial cell injury induced by hydrogen peroxide[J]. Acta Pharmacol Sin(�й�ҩ��ѧ��), 2010, 31(4)�� 485-492. [42] TANG J W, WANG D, FANG T H, et al. Prevention and treatment of bilirubin in rats with experimental hyperlipemia[J]. Med J Chin PAPF(�侯ҽѧ), 2010, 21(3)�� 195-196. [43] ZHANG Y Y, ZHOU Y, WANG L J, et al. A method ological study of determination of ursodeoxycholic acid in plasma[J]. Pharm J Chin PLA(��ž�ҩѧѧ��), 2010, 26(1)��42-43. [44] JI Y, ZHANG Y N, KANG X X, et al. The effect of polyene phosphatidylcholine on hepatic iron overload in rats with alcoholic liver damage[J]. J Clin Hepatol(ʵ�ø��ಡ��־), 2010, 13(5)�� 335-338. [45] LI Z D, YIN R, ZHU J Q, et al. Effects of n-3 fatty acids on cardiac allograft vasculopathy[J]. J Clin Rehabilit Tissue Eng Res(�й���֯�����о����ٴ�����), 2010, 14(5)�� 833-837. [46] SHEN G P, LIANG C L, GE Q P, et al. Study on optimization of 5-fluorouracil magnetic solid lipid nanoparticles[J]. J Zhengzhou Univ(Eng Sci) [֣�ݴ�ѧѧ��(��ѧ��)], 2010, 31(3)�� 16-19. [47] XIAO Y Y, LIU F, CHEN Z P, et al. Microemulsion-based gel of fluorouracil for transdermal delivery[J]. Acta Pharm Sin(ҩѧѧ��), 2010, 45 (11)�� 1440-1446. [48] YAN S F, ZHU J, WANG Z C, et al. Layer-by-layer assembly of poly(l-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil[J]. Eur J Pharm Biopharm, 2010, 30��12��. [Epub ahead of print]. [49] ZHAN Y L, LI C Y, LIU D M, et al. Study on the quantitative detection of bacterial endotoxin test for ribavirin infusion[J]. Chin Med Herald(�й�ҽҩ����), 2010, 7 (21)�� 47-48. [50] PI F M, TU X D, WU Y. Preparation of ATP-2Na loaded liposome and its effect on tissues energy state in myocardial ischemic mice[J]. Acta Pharm Sin(ҩѧѧ��), 2010, 45 (10)�� 1322-1326. [51] WANG Y, WANG W, HE Z K, et al. Determination of adenosine disodium triphosphate using water solubility cation fluorescent conjugated polymer as a fluorescence probe[J]. Chin J Anal Chem(������ѧ�о���), 2010, 38(5)�� 711-714.
[1] Ԭ��񴣬���������Źڻ� .ϸ�������붯������Ӳ��������ҩ���о���չ[J]. �й�ҩѧ��־, 2012,47(8): 569-572
[2] ��÷ ������.����ͪ����ǰ��֬�����Ƽ���Caco-2ϸ��ת���о�[J]. �й�ҩѧ��־, 2012,47(7): 529-533
[3] ������ ��÷ ����Ӣ.�ຣ��������ȺCYP2C19�����̬���о�[J]. �й�ҩѧ��־, 2012,47(7): 539-542
[4] ����ɺ ������ ��� ���� ���з� �Ʒ��.�������ͶԲ���ù����С�����ά���ĸ�Ԥ���ü���-ƽ�����������ױ���Ӱ��[J]. �й�ҩѧ��־, 2012,47(7): 504-511
[5] �°��� ��ѩ �ŷ� .��ͬ��Է����������������������Ѫ˨���ԱȽϼ�����̽��[J]. �й�ҩѧ��־, 2012,47(6): 431-434
[6] ��С��.������ø-2���������Ƽ�������������[J]. �й�ҩѧ��־, 2012,47(5): 399-
[7] Ф���� ���� ��� ƽ���� ��־�� .������A��������֬��������Ʊ�������[J]. �й�ҩѧ��־, 2012,47(5): 362-366
[8] ½���� ���� .�鵰��ȥ������ø���Ƽ��ڷ�����������о���չ[J]. �й�ҩѧ��־, 2012,47(5): 321-324
[9] �߻��� ����� .����ϸ����ҩ��ø������-������ø���о���չ[J]. �й�ҩѧ��־, 2012,47(5): 325-330
[10] ����� ������ .��ѪС��ҩ���о���չ[J]. �й�ҩѧ��־, 2012,47(4): 250-254
[11] ���� ������ ���� ������ ��ǭ�� �����.����ͪ��A�����ƶ�Ang ���յ����ļ�ϸ������Ӧ����Ӱ��[J]. �й�ҩѧ��־, 2012,47(4): 270-273
[12] ����� ����Ӿ .NHE-1���ữ��øRSK�������Ƽ����о���չ[J]. �й�ҩѧ��־, 2012,47(4): 241-244
[13] ���� ��ѩ�� ��� ���� ���� ���ٹ� .ע���������������׽ṹ֬������ϵͳ���Ʊ���������ҩ������ҩ��ѧ�о�[J]. �й�ҩѧ��־, 2012,47(4): 287-290
[14] ���ǿ� �·��� ֣��Ȩ ������ .����������ܹ���������ĺϳɼ���θ��ϸ������������[J]. �й�ҩѧ��־, 2012,47(4): 265-269
[15] ��ͩ�� ���� ������ ������ ���.��ҩ�Ĺ��ϸ��ɫ��b���������Լ����о�[J]. �й�ҩѧ��־, 2012,47(3): 182-
Copyright 2010 by �й�ҩѧ��־